Normal pregnancy is associated with the presence of circulating placental microvesicles (MVs). Increased MV shedding and altered immune activation are seen in patients with preeclampsia, suggesting that placental MVs may play a role in the pathophysiology of this disease. Therefore, the aim of this study was to investigate the activation of peripheral blood mononuclear cells (PBMCs) by MVs shed by first-trimester, normal term, and preeclamptic term placenta. First-trimester and preeclamptic term, but not normal term, placental-derived MVs activated PBMCs, as evidenced by elevated IL1B. Significant changes were also seen with several other cytokines and chemokines, and in general when compared to normal term MVs, preeclamptic MVs induced a greater pro-inflammatory response in PBMCs. Pretreatment of PBMCs with first-trimester or normal term placental MVs resulted in a dampened IL1B response to a subsequent lipopolysaccharide (LPS) challenge. In contrast, treatment of PBMCs with preeclamptic term placental MVs exacerbated the LPS response. This was also the case for several other cytokines and chemokines. These studies suggest that placental MVs can modulate basal peripheral immune cell activation and responsiveness to LPS during normal pregnancy, and that in preeclampsia this effect is exacerbated.
INTRODUCTION
Preeclampsia affects 5%-8% of pregnancies and is characterized by maternal hypertension and proteinuria after 20 wk of gestation [1] . While the etiology remains uncertain, it is a multifactorial disease with a number of characteristics, including poor placentation [2] , endothelial dysfunction [3] , altered placental angiogenesis [4] , and excessive maternal systemic inflammation [5] . Furthermore, the presence of the placenta, rather than the fetus, is a prerequisite for the disease because preeclampsia has been described in molar pregnancies in which there is placental but no fetal development [6] .
During normal pregnancy, the placenta constitutively releases microparticles/microvesicles (.100 nm) and exosomes (,100 nm), from its outer syncytiotrophoblast layer [7] , and these are readily detected in the maternal circulation [8] [9] [10] . Because both types of particle are known to play a role in cell-cell communication [7, 11] , the shedding of this placental material may be important in regulating the maternal immune system, which is critical for the maintenance of normal pregnancy [12] . Indeed, a number of studies have demonstrated that placental-derived microvesicles (MVs) and exosomes contain proteins and RNA [13] [14] [15] [16] [17] [18] [19] [20] . Moreover, placentalderived MVs [18, [21] [22] [23] [24] [25] [26] [27] [28] and exosomes [10, 16, 29] can modulate the function of immune and endothelial cells, cell types that exhibit aberrant activation status in preeclampsia. In preeclampsia, placental shedding is increased, leading to elevated levels of circulating MVs [8, 22] , which, therefore, could be a possible cause of the heightened inflammation seen in the syndrome [30] [31] [32] . However, little is known about the intrinsic immunomodulatory effect of particles shed from a pathological placenta. Therefore, the objective of this study was to investigate the activation of peripheral blood immune cells by MVs shed from first-trimester, normal term, and preeclamptic term placenta.
MATERIALS AND METHODS

Patient Samples
First-trimester placentas were obtained following elective social terminations of pregnancy (8-12 wk) (n ¼ 6). Normal term placentas (n ¼ 6) and term preeclamptic placentas (n ¼ 5) were obtained following Cesarean section or spontaneous vaginal delivery (37-42 wk) . Both were with written informed patient consent and local ethics committee approval. Exclusion criteria were: twin pregnancy, maternal infection, diabetes, preexisting hypertension, and babies with chromosomal abnormalities. Preeclamptic pregnancies were defined by new hypertension arising after 20-wk gestation of over 140/90 mm Hg on two occasions and concurrent proteinuria of at least 0.3 g over 24 h. All the babies with a normal birth weight centile, defined by an individualized birth weight ratio between the 10th and 90th percentile, were included. Villous tissue was washed in sterile PBS, and dissected in 1:1 DMEM/F12 (Gibco/ Lonza) containing 2 mM L-glutamine, 100 lg/ml streptomycin, and 100 units/ ml penicillin (GSP) (Gibco).
Placental MV Generation
Placental villous explants (2-4mm 2 ) were placed into 47 lm mesh Netwells (Corning) in serum-free 1:1 DMEM/F12 with GSP and incubated for 24 h in 6% oxygen and 5% CO 2 at 378C. Medium containing shed material was collected from the bottom of the microplates and pooled, then transferred to sterile ultracentrifuge tubes and subjected to a three-step centrifugation at 48C: 1000 3 g for 10 min, 10 000 3 g for 10 min, and 70 000 3 g for 90 min. The final MV-containing pellet was resuspended in sterile PBS.
Transmission Electron Microscopy
Microvesicle pellets and tissue were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.3, for 30 min and 4 h, respectively, and then washed three times in 0.1 M sodium cacodylate buffer containing 3 mM calcium chloride over 24h. Postfixation was carried out with 1% osmium tetroxide (Agar Scientific) in 0.05 M sodium cacodylate buffer, pH 7.3, for 1 h at 48C followed by dehydration in an ascending alcohol series, treatment with propylene oxide, and overnight incubation in a 1:3 mix of propylene oxide and epoxy resin (Taab Laboratories Equipment). The following day, specimens were given two changes of fresh resin at 458C for 1 h each before being embedded in gelatin capsules and polymerized for 72 h at 608C. Semithin sections of 0.5 lm were cut on a Reichert Ultracut microtome, stained with 1% toluidine blue in 1% borax, after which ultrathin sections were prepared with a diamond knife, mounted on copper grids and stained with uranyl acetate and lead citrate. These were visualized using a Philips CM10 electron microscope at an accelerating voltage of 80 kV, and 4 MB digital images were captured using a Deben camera.
Peripheral Blood Mononuclear Cell Isolation and Activation
Venous blood from nonpregnant healthy donors was collected, and peripheral blood mononuclear cells (PBMCs) was isolated using Histopaque 1077 (Sigma) and plated in 24-well low-binding HydroCell plates (Nunc) at 1 3 10 6 cells per well in 250 ll of OptiMem (Life Technologies). After resting for 2 h at 378C, PBMCs were treated with 20 lg/ml of sterile MVs. Treatment with 10 ng/ml lipopolysaccharide (LPS) isolated from Escherichia coli (serotype 0111:B4; Sigma) served as a positive control. After 24 h, cell-free supernatants were collected and stored at À808C. For priming experiments, PBMCs were pretreated with or without MVs (20 lg/ml) for 2 h, followed by incubation with media alone or LPS (10 ng/ml) for 24 h. Supernatants were analyzed for IL1B by ELISA (R&D Systems) and for levels of IL1B, IL2, IL6, IL8, IL10, IL12, IL17, CSF3 (G-CSF), CSF2 (GM-CSF), IFNG (IFN-c), CCL2 (MCP-1), CCL3 (MIP-1 a), CCL4 (MIP-1b), CCL5 (RANTES), VEGFA (VEGF), TNF (TNF-a), and CXCL1 (GRO-a) using a custom 17-Bio-Plex assay (Bio-Rad) run in duplicate on the Luminex multiplex 200 system (Upstate Biotechnology).
Statistical Analysis
For the effects of MVs on PBMC activation, data were analyzed using the Mann-Whitney U-test. For analysis of the effects of MVs on the LPS response, the data were expressed as LPS-induced fold change in IL1B production and then compared to LPS alone with no pretreatment (media) by one-way Student t-test.
RESULTS
The Placental Syncytial Surface and MVs Shed from Explants Show Altered Morphology in Preeclampsia
Transmission electron microscopy demonstrated the presence of abundant MVs in the size range of 100 nm-1 lm following isolation from explant culture medium by ultracentrifugation (Fig. 1A ). Both faces of the MV membrane were associated with amorphous material, some of which contained dense granules. Some MVs were sealed while others were open-ended. Preparations from normal term placental explants showed an increased proportion of larger MVs compared to preparations from first-trimester placental explants. In addition, MVs released from preeclamptic placental explants appeared larger than those released from normal term placental explants, with more unsealed MVs and more particulate material (Fig.  1A) . These larger and less regular vesicles are unlikely to indicate the presence of apoptotic bodies because these normally appear as blebs of condensed chromatin, which are not evident in the electron micrographs. The dark bodies are mostly mitochondria, with some secretory droplets.
Some of the open-ended vesicles could be microvilli that have been pinched off from the placental surface. The surface of normal term placenta is characterized by microvilli (Fig. 1B) while in preeclampsia, the surface is disrupted, with less intact microvilli and some exposure of the cytotrophoblast to the maternal circulation.
First-Trimester and Preeclamptic Term MVs Induce Higher Immune Cell Activation than Normal Term MVs
We investigated the effect of MVs from first-trimester, normal term, and preeclamptic term placenta on the activation status of immune cells. PBMCs were maintained in suspension in low-binding plates and incubated with MVs shed from placental explants. IL1B secretion was initially measured as a marker of a pro-inflammatory response. Microvesicles shed from first-trimester placental explants significantly elevated IL1B secretion by PBMCs ( Fig. 2A) . Normal term placental MVs had no effect on PBMC IL1B secretion (Fig. 2B) . However, treatment with MVs shed from preeclamptic placental explants showed a significant increase in PBMC IL1B secretion (Fig. 2B) , which is similar to what was seen with first-trimester MVs. We further explored the effect of MVs on PBMCs through multiplex analysis of cytokine and chemokine secretion. First-trimester MVs induced elevated production of IL4, IL6, IL8, IL10, IL17, CSF3 (G-CSF), CCL2 (MCP-1), CCL3 (MIP-1a), CCL4 (MIP-1b), CCL5 (RANTES), TNF (TNF-a), VEGFA (VEGF), and CXCL1 (GRO-a) by PBMCs (Table 1 ). IL2 production was decreased. Both normal term and preeclamptic MVs induced the upregulation of IL8, CSF3 (G-CSF), CCL4 (MIP-1b), CCL5 (RANTES), TNF (TNF-a), and CXCL1 (GRO-a) secretion by PBMCs (Table 1) . Normal term, but not preeclamptic MVs, upregulated CCL2 (MCP-1) and, like first-trimester MVs, suppressed IL2 production. Microvesicles from preeclamptic but not normal term significantly increased production of IL6, IL10, IL17, and CCL3 (MIP-1a). Furthermore, when comparing the effects of preeclamptic and normal term MVs on PBMCs, preeclamptic MVs induced significantly greater upregulation of IL6, IL17, CCL3 (MIP-1a), CCL4 (MIP-1b), and TNF (TNF-a) when compared to normal term MVs. Preeclamptic MVs did not alter IL2 production, and the preeclamptic MV-induced increase in CCL2 (MCP-1) and CXCL1 (GRO-a) production was significantly less than with normal term MVs. In general, when compared to normal term MVs, preeclamptic MVs induced a greater pro-inflammatory response in the PBMCs.
Microvesicles Shed by Placentas from Early Pregnancy and Normal Term Induce LPS Tolerance, while Preeclamptic Placental MVs Induce a Heightened Pro-Inflammatory Response to LPS
The effect of placental MVs on the immune cell response to an infectious TLR4 stimulus was determined by pretreating PBMCs with media alone or placental MVs, followed by challenge with low-dose LPS. Untreated PBMCs showed significantly elevated levels of IL1B in response to LPS, and this was given an arbitrary value of 1 (Fig. 3) . Pretreatment of PBMCs with either MVs from first-trimester or normal term placenta significantly reduced the LPS-induced production of IL1B by PBMCs (Fig. 3, A and B) . In contrast, MVs from preeclamptic placentas augmented the LPS-induced IL1B response (Fig. 3B) . Multiplex analysis demonstrated that first-trimester MVs had, for the most part, no effect on the production of 17 other cytokines and chemokines, only inducing a reduction in TNF (TNFa) production in response to LPS (Table 2) . Similarly, normal term MVs had largely no effect on the production of these other factors, only inducing a reduction in CCL2 (MCP-1) production in response to LPS HOLDER ET AL. The apical surface of the syncytiotrophoblast as viewed by electron microscopy. Left: the scalloped profile of a first-trimester villus is shown bearing numerous microvilli cut in both transverse and longitudinal sections. Center: at term, the microvilli are generally shorter and many can be seen to have clavate tips, some of which may detach to form microvesicles although the microvilli here may also be cut in transverse section. Right: in preeclampsia, large swathes of cytoplasm may detach from the surface of the syncytium, which bears irregularly distributed, distorted microvilli. (Table 2 ). In contrast, and similar to the IL1B response, preeclamptic MVs significantly elevated the LPS-induced production of IL4, IL6, IL10,
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CSF3 (G-CSF), CSF2 (GM-CSF), CCL3 (MIP-1a), CCL5 (RANTES), TNF (TNF-a), VEGFA (VEGF), and CXCL1 (GRO-a).
DISCUSSION
Little is known about how placental MVs in the circulation condition the maternal immune system, and, despite speculation, the effects of normal and preeclamptic MVs on immune cell activation have not been previously compared. This study shows, for the first time, that first-trimester and preeclamptic term MVs, but not normal term MVs, activate PBMCs to produce IL1B. Furthermore, electron microscopy demonstrated differing morphology of MVs in preeclampsia.
Previous studies have utilized different methods for generating placental MVs, such as mechanical disruption, explant culture, or perfusion, at different oxygen tensions, with varying effects on immune cell activation [18, 22, 24] . Because perfusion systems have yet to be developed for first-trimester placenta but villous explant cultures have the benefit of keeping the tissue continually bathed in medium, we chose the latter approach. Microvesicles were generated at 6% oxygen, the estimated physiological level in normal placenta after 11 wk [33, 34] . It is vital to note carefully the method used for isolation of shed material fractions when interpreting findings in this field, taking into account the size of the target material. The procedure used in the current study enriches for MVs from the apical syncytioplasm and thus, is suitable to use for comparisons between MVs from different placentas. Larger material was excluded by initial centrifugation. The final spin of 70 000 3 g was chosen to avoid pelleting exosomes, which are expected to sediment at 100 000 3 g [11] . Furthermore, electron microscopy demonstrated that contamination with exosomes was minimal. For coculture experiments, PBMCs were kept in low-binding tissue culture plates to more closely mimic their nonadherent in vivo state.
We chose initially to measure IL1B as a marker of inflammatory responses in PBMCs. Microvesicles shed from first-trimester placenta activated PBMCs to increase IL1B PBMCs were treated with 20 lg/ml placental microvesicles shed by first-trimester placenta (first trimester, n ¼ 6), normal term placenta (term normal, n ¼ 6), or preeclamptic term placenta (term PE, n ¼ 5). Following a 24-h incubation, supernatants were collected, pooled, and assayed by multiplex. Numbers represent fold change of cytokine/chemokine production after treatment with MV compared to no treatment (NT). *P , 0.05, **P , 0.01, ***P , 0.001, unpaired t-test relative to the NT control; ns, no significant difference. b For PE MV treatment compared to normal term MV responses, indicates a significant increase and z indicates a significant decrease.
FIG. 3. Effect of priming PBMCs with placental
MVs on their response to LPS. PBMCs were pretreated with either (A) no treatment (media) or 20 lg/ml of first-trimester MVs (1st trimester MV) or (B) no treatment (media), 20 lg/ml of normal term placental-derived MVs (normal MV), or 20 lg/ml of preeclamptic term placental-derived MVs (PE MV) for 2 h. After this pretreatment, all the cells were then treated with LPS for 24 h, and the supernatants were assayed for IL1B by ELISA. The bar chart shows the fold change in LPS-induced IL1B production relative to LPS alone with no pretreatment (media), which was set at 1. Values are shown as mean 6 SD. *P , 0.05, ** P , 0.01, ***P , 0.001. a, compared to response to LPS in media by one sample t-test; b, LPS response compared between preeclamptic MV treatment and normal term MV treatment by unpaired t-test.
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secretion, while normal term placental MVs did not. This differential effect suggests that normal early pregnancy is a state of controlled inflammation [30, 35] , which lessens as gestation proceeds, and this is supported by a recent study that investigated PBMC inflammatory responses [22] . Also, just like the MVs used in this study, first-trimester trophoblastderived exosomes induce an IL1B response in monocytederived macrophages [36] . While previous researchers have found that normal term placental-derived MVs can stimulate immune cells, their studies differ from ours in both MV preparation methods and immune cell endpoints [18, 22, 24] . One study showed that normal term placental explant-derived MVs stimulate neutrophils [23] , but granulocytes were excluded from our studies. In another study using term explant-derived MVs, monocytes became activated, however, only when the explants were cultured under hyperoxic conditions (20%) and not under normoxic conditions (3%) [18] . In the present study, term placental explants cultured under normoxic conditions (6%) generated MVs that were not pro-inflammatory, validating our culture conditions. In addition to IL1B, we measured a number of other cytokines and chemokines to further understand the effect of MVs on immune cells. First-trimester MVs also upregulate IL4, IL6, IL8, IL10, IL12, IL17, CSF3 (G-CSF), CCL2 (MCP-1), CCL3 (MIP-1a), CCL4 (MIP-1b), CCL5 (RANTES), TNF (TNF-a), VEGFA (VEGF), and CXCL1 (GRO-a) production by PBMCs, while IL2 is downregulated. Both pro-inflammatory and anti-inflammatory molecules are represented in this profile, reflecting the pregnant immune system, which bears markers of both immune activation and dampening. Maternal molecules induced by first-trimester MVs may cycle back to influence early placental development.
Multiplex cytokine/chemokine analysis also allowed the demonstration that, although normal term placental MVs do not induce IL1B production as previously been shown [18] , there is still an increase in IL8, CSF3 (G-CSF), CCL2 (MCP-1), CCL4 (MIP-1b), CCL5 (RANTES), TNF (TNFa), and CXCL1 (GRO-a) production by PBMCs. Like first-trimester MVs, MVs from normal term, but not preeclamptic placental MVs, reduced IL2 production by PBMC, in support of evidence that serum IL2 is reduced in normal, but not pathological, pregnancy [37] . Also in contrast to normal term MV, we found that MVs shed from preeclamptic placenta upregulated PBMC secretion of IL6, IL8, IL10, IL17, CSF3 (G-CSF), CCL3 (MIP-1a), CCL4 (MIP-1b), CCL5 (RANTES), TNF (TNF-a), and CXCL1 (GRO-a), and in general, the levels of these, mostly pro-inflammatory factors, were greater in response to the preeclamptic MVs.
Preeclampsia is associated with aberrant cell turnover, increased trophoblast apoptosis [38] , and increased placental debris in the maternal circulation [9, 22, 39] . It has, therefore, been hypothesized that the increased immune cell and endothelial activation associated with preeclampsia are related to increased quantities of circulating placental MVs [31, 35] . However, in our studies, the same amount of MV protein was used for each treatment, suggesting that factors intrinsic to preeclamptic MVs are responsible for the heightened response when compared to the normal term MVs. Therefore, in preeclampsia, in addition to increased numbers of circulating MVs, our experiments may indirectly indicate an altered MV quality. This might be due to alterations in normal cell turnover processes, resulting in inappropriate MV assembly, as suggested by electron microscopic studies of normal and preeclamptic syncytial surfaces [40] .
When the ability of placental MVs to influence PBMC responses to LPS was examined, as a model of infection in pregnancy, it emerged that first-trimester and normal term placental-derived MVs effectively dampened pro-inflammatory IL1B production induced by LPS. This is indicative of endotoxin tolerance as seen in sepsis, a state to which normal pregnancy has been compared to [41] . While PBMCs from pregnant women have a generally higher capacity for cytokine production than those from nonpregnant women [42, 43] , there is evidence for a change during gestation. Some studies report a decrease in pro-inflammatory capacity with dampening of the response to microbial stimulation [44, 45] , but others have reported more monocyte-derived IL12 in response to LPS [46] . Thus, it appears that skewing adjusts the maternal response to PBMCs were pretreated with either media or 20 lg/ml placental microvesicles shed by first-trimester placenta (first trimester, n ¼ 6), normal term placenta (term normal; n ¼ 6), or preeclamptic term placenta (term PE, n ¼ 5) for 2 h followed by LPS for 24 h. Supernatants were collected, pooled, and assayed by multiplex. Numbers represent fold change of cytokine/chemokine production in response to LPS and are normalized to the fold change for PBMCs treated with LPS in the absence of MV (media). *P , 0.05, **P , 0.01, ***P , 0.001, unpaired t test relative to the untreated control; ns, no significant difference. b For PE MV/LPS treatment compared to normal term MV/LPS responses, indicates a significant increase.
IMMUNE CELL ACTIVATION BY PLACENTAL MICROVESICLES microbial challenge rather than effecting a global suppression, and we suggest that MV release and maternal recognition play important roles in this process. Indeed, we found that most other cytokine/chemokine responses to LPS were unchanged, with the exception of TNF (TNFa), which was reduced by first-trimester MVs, and CCL2 (MCP-1), which was reduced by normal term MVs. In contrast to the picture in normal pregnancy, pretreatment of PBMCs with preeclamptic MVs augmented LPS-induced PBMC IL1B production as well as a number of other factors, including IL6, TNF (TNF-a), CCL5 (RANTES), and CXCL1 (GRO-a). How the preeclamptic MVs sensitize PBMCs to LPS is the focus of ongoing investigation. Nonetheless, this finding supports the notion that preeclampsia is a state of exaggerated inflammation compared to normal term pregnancy [35, 41] . In parallel studies, we have shown that syncytin 1, a human endogenous retroviral protein, is present in placental MVs and can contribute to immune cell activation and modulation of LPS-induced immune cell responses [47] . Because several studies have shown that syncytin 1 levels change during gestation and in preeclampsia [48, 49] , we believe this may explain some of the observed changes in MV-mediated immune activation. This study demonstrates that first-trimester placental MVs are, in general, pro-inflammatory by activating PBMCs. However, later in gestation, this response is diminished, even though MVs are still detectable in the maternal circulation. Furthermore, our studies show that placental MVs can modulate immune cell responsiveness to LPS differentially at different times of pregnancy and in preeclampsia. Enhanced understanding of the role of MVs in the aberrant immune response associated with preeclampsia could ultimately lead to development of therapies to help reduce the pathology associated with this disease.
